Fused bicyclic heteroaryl compounds as NLRP3 inhibitors

The present invention relates to novel compounds having the general formula Ic, # imgabs0 # wherein R1, R2, R3, R8, R9, RX, A1, A2, W and n are as described herein; compositions comprising the compounds; and methods of using the compounds. 本发明涉及具有通式Ic的新颖化合物，#imgabs0#其中R1、R2、R3、R8、R9、RX、A1、A2、W和n如本文所...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GUBA, WOLFGANG, AITKEN LINDA SUE, SHANNON JONATHAN MARTIN, PATINY-ADAM, ANDR, JAESCHKE GEORG, JOHNSTON, H., JOHN, MESCH, SCOTT, K, SCHNIEDER CHRISTIAN, STEINER SANDRA, TOSTOV ALEXANDER MIKHAILOVICH, BUSH LAWRENCE A
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to novel compounds having the general formula Ic, # imgabs0 # wherein R1, R2, R3, R8, R9, RX, A1, A2, W and n are as described herein; compositions comprising the compounds; and methods of using the compounds. 本发明涉及具有通式Ic的新颖化合物，#imgabs0#其中R1、R2、R3、R8、R9、RX、A1、A2、W和n如本文所述；包含所述化合物的组合物；以及使用所述化合物的方法。